Capital Research and Management Company - Division 3 »

Aeglea Biotherapeutics shares owned by Capital Research and Management Company - Division 3

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Capital Research and Management Company - Division 3 from 13F filings

Historical chart of Capital Research and Management Company - Division 3 investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Capital Research and Management Company - Division 3 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Capital Research and Management Company - Division 3

Quarter filed Position value Share count Share price at filing
2025-09-30 $40M 2.4M 16.76
2025-06-30 $36M 2.4M 14.97
2025-03-31 $39M 2.4M 16.14